Advertisement

Index by Author

December 1998; 47 (12)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Ader, M

    • Biphasic insulin secretion during intravenous glucose tolerance test promotes optimal interstitial insulin profile. Diabetes December 1998 47:1941-1947; doi:10.2337/diabetes.47.12.1941

  2. Ahvazi, B

    • Alpha-interferon inhibits the development of diabetes in NOD mice. Diabetes December 1998 47:1867-1872; doi:10.2337/diabetes.47.12.1867

  3. Aiello, L P

    • Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes December 1998 47:1894-1903; doi:10.2337/diabetes.47.12.1894

  4. Akanuma, Y

    • A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats. Diabetes December 1998 47:1841-1847; doi:10.2337/diabetes.47.12.1841

  5. Albuquerque-Silva, J

    • Contribution of Na/Ca exchange to Ca2+ outflow and entry in the rat pancreatic beta-cell: studies with antisense oligonucleotides. Diabetes December 1998 47:1873-1880; doi:10.2337/diabetes.47.12.1873

  6. Antonetti, D A

    • Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes December 1998 47:1953-1959; doi:10.2337/diabetes.47.12.1953

B

  1. Baekkeskov, S

    • Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells. Diabetes December 1998 47:1848-1856; doi:10.2337/diabetes.47.12.1848

  2. Baldwin, A C

    • Adaptation to hyperglycemia enhances insulin secretion in glucokinase mutant mice. Diabetes December 1998 47:1881-1888; doi:10.2337/diabetes.47.12.1881

  3. Bao, S

    • Expression of mRNAs encoding uncoupling proteins in human skeletal muscle: effects of obesity and diabetes. Diabetes December 1998 47:1935-1940; doi:10.2337/diabetes.47.12.1935

  4. Barber, A J

    • Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes December 1998 47:1953-1959; doi:10.2337/diabetes.47.12.1953

  5. Bell, G I

    • Adaptation to hyperglycemia enhances insulin secretion in glucokinase mutant mice. Diabetes December 1998 47:1881-1888; doi:10.2337/diabetes.47.12.1881

  6. Bergman, R N

    • Biphasic insulin secretion during intravenous glucose tolerance test promotes optimal interstitial insulin profile. Diabetes December 1998 47:1941-1947; doi:10.2337/diabetes.47.12.1941

  7. Bingley, P J

    • Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes December 1998 47:1857-1866; doi:10.2337/diabetes.47.12.1857

  8. Bonifacio, E

    • Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes December 1998 47:1857-1866; doi:10.2337/diabetes.47.12.1857

  9. Bonner-Weir, S

    • Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes December 1998 47:1894-1903; doi:10.2337/diabetes.47.12.1894

  10. Bosco, D

    • Sorting human beta-cells consequent to targeted expression of green fluorescent protein. Diabetes December 1998 47:1974-1977; doi:10.2337/diabetes.47.12.1974

  11. Bridgett, M

    • Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells. Diabetes December 1998 47:1848-1856; doi:10.2337/diabetes.47.12.1848

  12. Brosnan, J T

    • Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes December 1998 47:1967-1970; doi:10.2337/diabetes.47.12.1967

  13. Brosnan, M E

    • Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes December 1998 47:1967-1970; doi:10.2337/diabetes.47.12.1967

C

  1. Cetkovic-Cvrlje, M

    • Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells. Diabetes December 1998 47:1848-1856; doi:10.2337/diabetes.47.12.1848

  2. Cockburn, B N

    • Adaptation to hyperglycemia enhances insulin secretion in glucokinase mutant mice. Diabetes December 1998 47:1881-1888; doi:10.2337/diabetes.47.12.1881

  3. Colman, P G

    • Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes December 1998 47:1857-1866; doi:10.2337/diabetes.47.12.1857

  4. Craft, S

    • Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes December 1998 47:1920-1927; doi:10.2337/diabetes.47.12.1920

  5. Crook, E D

    • Regulation of glutamine:fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase. Diabetes December 1998 47:1836-1840; doi:10.2337/diabetes.47.12.1836

  6. Cryer, P E

    • Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes December 1998 47:1920-1927; doi:10.2337/diabetes.47.12.1920

D

  1. Damjancic, P

    • Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment. Diabetes December 1998 47:1909-1914; doi:10.2337/diabetes.47.12.1909

  2. Daniels, M C

    • Regulation of glutamine:fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase. Diabetes December 1998 47:1836-1840; doi:10.2337/diabetes.47.12.1836

  3. Dea, M K

    • Biphasic insulin secretion during intravenous glucose tolerance test promotes optimal interstitial insulin profile. Diabetes December 1998 47:1941-1947; doi:10.2337/diabetes.47.12.1941

  4. de Vargas, L M

    • Sorting human beta-cells consequent to targeted expression of green fluorescent protein. Diabetes December 1998 47:1974-1977; doi:10.2337/diabetes.47.12.1974

E

  1. Edlund, H

    • Transcribing pancreas. Diabetes December 1998 47:1817-1823; doi:10.2337/diabetes.47.12.1817

  2. Eisenbarth, G S

    • Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes December 1998 47:1857-1866; doi:10.2337/diabetes.47.12.1857
    • Transmission of DQ haplotypes to patients with type 1 diabetes. Diabetes December 1998 47:1971-1973; doi:10.2337/diabetes.47.12.1971

  3. Elliott, T

    • Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes. Diabetes December 1998 47:1915-1919; doi:10.2337/diabetes.47.12.1915

  4. Eriksson, U J

    • Teratogenicity of 3-deoxyglucosone and diabetic embryopathy. Diabetes December 1998 47:1960-1966; doi:10.2337/diabetes.47.12.1960

  5. Erlich, H

    • Transmission of DQ haplotypes to patients with type 1 diabetes. Diabetes December 1998 47:1971-1973; doi:10.2337/diabetes.47.12.1971

F

  1. Fain, P R

    • Transmission of DQ haplotypes to patients with type 1 diabetes. Diabetes December 1998 47:1971-1973; doi:10.2337/diabetes.47.12.1971

  2. Fanelli, C G

    • Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes December 1998 47:1920-1927; doi:10.2337/diabetes.47.12.1920

  3. Fasching, P

    • Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment. Diabetes December 1998 47:1909-1914; doi:10.2337/diabetes.47.12.1909

  4. Ferguson, T

    • Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes. Diabetes December 1998 47:1904-1908; doi:10.2337/diabetes.47.12.1904

  5. Finegood, D

    • Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes. Diabetes December 1998 47:1915-1919; doi:10.2337/diabetes.47.12.1915

  6. Forbes, A

    • Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes. Diabetes December 1998 47:1915-1919; doi:10.2337/diabetes.47.12.1915

  7. Ford, G C

    • Differential regulation of amino acid exchange and protein dynamics across splanchnic and skeletal muscle beds by insulin in healthy human subjects. Diabetes December 1998 47:1824-1835; doi:10.2337/diabetes.47.12.1824

G

  1. Gagnon, A

    • Expression and regulation of neuronal apoptosis inhibitory protein during adipocyte differentiation. Diabetes December 1998 47:1948-1952; doi:10.2337/diabetes.47.12.1948

  2. Ganaway, E

    • Expression of mRNAs encoding uncoupling proteins in human skeletal muscle: effects of obesity and diabetes. Diabetes December 1998 47:1935-1940; doi:10.2337/diabetes.47.12.1935

  3. Gardner, T W

    • Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes December 1998 47:1953-1959; doi:10.2337/diabetes.47.12.1953

  4. Garvey, W T

    • Expression of mRNAs encoding uncoupling proteins in human skeletal muscle: effects of obesity and diabetes. Diabetes December 1998 47:1935-1940; doi:10.2337/diabetes.47.12.1935

  5. Getty, L

    • Biphasic insulin secretion during intravenous glucose tolerance test promotes optimal interstitial insulin profile. Diabetes December 1998 47:1941-1947; doi:10.2337/diabetes.47.12.1941

  6. Grimm, G

    • Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment. Diabetes December 1998 47:1909-1914; doi:10.2337/diabetes.47.12.1909

  7. Grupe, A

    • Adaptation to hyperglycemia enhances insulin secretion in glucokinase mutant mice. Diabetes December 1998 47:1881-1888; doi:10.2337/diabetes.47.12.1881

  8. Gulve, E A

    • Regulation of glutamine:fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase. Diabetes December 1998 47:1836-1840; doi:10.2337/diabetes.47.12.1836

H

  1. Halban, P A

    • Sorting human beta-cells consequent to targeted expression of green fluorescent protein. Diabetes December 1998 47:1974-1977; doi:10.2337/diabetes.47.12.1974

  2. Hamilton-Wessler, M

    • Biphasic insulin secretion during intravenous glucose tolerance test promotes optimal interstitial insulin profile. Diabetes December 1998 47:1941-1947; doi:10.2337/diabetes.47.12.1941

  3. Hanefeld, M

    • In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance. Diabetes December 1998 47:1928-1934; doi:10.2337/diabetes.47.12.1928

  4. Herchuelz, A

    • Contribution of Na/Ca exchange to Ca2+ outflow and entry in the rat pancreatic beta-cell: studies with antisense oligonucleotides. Diabetes December 1998 47:1873-1880; doi:10.2337/diabetes.47.12.1873

  5. Hershey, T

    • Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes December 1998 47:1920-1927; doi:10.2337/diabetes.47.12.1920

  6. Higa, M

    • Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes. Diabetes December 1998 47:1904-1908; doi:10.2337/diabetes.47.12.1904

  7. Hoffman, R T

    • Regulation of glutamine:fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase. Diabetes December 1998 47:1836-1840; doi:10.2337/diabetes.47.12.1836

  8. House, J D

    • Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes December 1998 47:1967-1970; doi:10.2337/diabetes.47.12.1967

  9. Huynh, Q K

    • Regulation of glutamine:fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase. Diabetes December 1998 47:1836-1840; doi:10.2337/diabetes.47.12.1836

I

  1. Ide, T

    • A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats. Diabetes December 1998 47:1841-1847; doi:10.2337/diabetes.47.12.1841

  2. Irminger, J C

    • Sorting human beta-cells consequent to targeted expression of green fluorescent protein. Diabetes December 1998 47:1974-1977; doi:10.2337/diabetes.47.12.1974

  3. Irsigler, K

    • Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment. Diabetes December 1998 47:1909-1914; doi:10.2337/diabetes.47.12.1909

J

  1. Jacobs, R L

    • Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes December 1998 47:1967-1970; doi:10.2337/diabetes.47.12.1967

  2. Julius, U

    • In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance. Diabetes December 1998 47:1928-1934; doi:10.2337/diabetes.47.12.1928

K

  1. Kadowaki, T

    • A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats. Diabetes December 1998 47:1841-1847; doi:10.2337/diabetes.47.12.1841

  2. Kawasaki, E

    • Transmission of DQ haplotypes to patients with type 1 diabetes. Diabetes December 1998 47:1971-1973; doi:10.2337/diabetes.47.12.1971

  3. Kennedy, A

    • Expression of mRNAs encoding uncoupling proteins in human skeletal muscle: effects of obesity and diabetes. Diabetes December 1998 47:1935-1940; doi:10.2337/diabetes.47.12.1935

  4. Khin, S

    • Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes December 1998 47:1953-1959; doi:10.2337/diabetes.47.12.1953

  5. Koyama, K

    • Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes. Diabetes December 1998 47:1904-1908; doi:10.2337/diabetes.47.12.1904

  6. Kramer, L

    • Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment. Diabetes December 1998 47:1909-1914; doi:10.2337/diabetes.47.12.1909

L

  1. Lambert, J

    • Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells. Diabetes December 1998 47:1848-1856; doi:10.2337/diabetes.47.12.1848

  2. Leahy, J L

    • Shared biochemical properties of glucotoxicity and lipotoxicity in islets decrease citrate synthase activity and increase phosphofructokinase activity. Diabetes December 1998 47:1889-1893; doi:10.2337/diabetes.47.12.1889

  3. Lebeau, C

    • Contribution of Na/Ca exchange to Ca2+ outflow and entry in the rat pancreatic beta-cell: studies with antisense oligonucleotides. Diabetes December 1998 47:1873-1880; doi:10.2337/diabetes.47.12.1873

  4. Lee, Y

    • Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes. Diabetes December 1998 47:1904-1908; doi:10.2337/diabetes.47.12.1904

  5. Leiter, E H

    • Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells. Diabetes December 1998 47:1848-1856; doi:10.2337/diabetes.47.12.1848

  6. Levisetti, M

    • Adaptation to hyperglycemia enhances insulin secretion in glucokinase mutant mice. Diabetes December 1998 47:1881-1888; doi:10.2337/diabetes.47.12.1881

  7. Lieth, E

    • Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes December 1998 47:1953-1959; doi:10.2337/diabetes.47.12.1953

  8. Liu, Y Q

    • Shared biochemical properties of glucotoxicity and lipotoxicity in islets decrease citrate synthase activity and increase phosphofructokinase activity. Diabetes December 1998 47:1889-1893; doi:10.2337/diabetes.47.12.1889

M

  1. Madl, C

    • Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment. Diabetes December 1998 47:1909-1914; doi:10.2337/diabetes.47.12.1909

  2. Magun, R

    • Expression and regulation of neuronal apoptosis inhibitory protein during adipocyte differentiation. Diabetes December 1998 47:1948-1952; doi:10.2337/diabetes.47.12.1948

  3. McClain, D A

    • Regulation of glutamine:fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase. Diabetes December 1998 47:1836-1840; doi:10.2337/diabetes.47.12.1836

  4. Meek, S E

    • Differential regulation of amino acid exchange and protein dynamics across splanchnic and skeletal muscle beds by insulin in healthy human subjects. Diabetes December 1998 47:1824-1835; doi:10.2337/diabetes.47.12.1824

  5. Meneilly, G S

    • Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes. Diabetes December 1998 47:1915-1919; doi:10.2337/diabetes.47.12.1915

  6. Meyer, K

    • Sorting human beta-cells consequent to targeted expression of green fluorescent protein. Diabetes December 1998 47:1974-1977; doi:10.2337/diabetes.47.12.1974

  7. Minhas, H S

    • Teratogenicity of 3-deoxyglucosone and diabetic embryopathy. Diabetes December 1998 47:1960-1966; doi:10.2337/diabetes.47.12.1960

  8. Mochizuki, T

    • A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats. Diabetes December 1998 47:1841-1847; doi:10.2337/diabetes.47.12.1841

  9. Morel, P

    • Sorting human beta-cells consequent to targeted expression of green fluorescent protein. Diabetes December 1998 47:1974-1977; doi:10.2337/diabetes.47.12.1974

  10. Moss, L G

    • Sorting human beta-cells consequent to targeted expression of green fluorescent protein. Diabetes December 1998 47:1974-1977; doi:10.2337/diabetes.47.12.1974

  11. Mulgrew, C L

    • Transmission of DQ haplotypes to patients with type 1 diabetes. Diabetes December 1998 47:1971-1973; doi:10.2337/diabetes.47.12.1971

  12. Murakami, K

    • A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats. Diabetes December 1998 47:1841-1847; doi:10.2337/diabetes.47.12.1841

N

  1. Nair, K S

    • Differential regulation of amino acid exchange and protein dynamics across splanchnic and skeletal muscle beds by insulin in healthy human subjects. Diabetes December 1998 47:1824-1835; doi:10.2337/diabetes.47.12.1824

  2. Narayanswami, S

    • Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells. Diabetes December 1998 47:1848-1856; doi:10.2337/diabetes.47.12.1848

  3. Nitzsche, S

    • In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance. Diabetes December 1998 47:1928-1934; doi:10.2337/diabetes.47.12.1928

  4. Noble, J

    • Transmission of DQ haplotypes to patients with type 1 diabetes. Diabetes December 1998 47:1971-1973; doi:10.2337/diabetes.47.12.1971

O

  1. O'Rourke, R

    • Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells. Diabetes December 1998 47:1848-1856; doi:10.2337/diabetes.47.12.1848

  2. Oberholzer, J

    • Sorting human beta-cells consequent to targeted expression of green fluorescent protein. Diabetes December 1998 47:1974-1977; doi:10.2337/diabetes.47.12.1974

  3. Ohashi, M

    • A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats. Diabetes December 1998 47:1841-1847; doi:10.2337/diabetes.47.12.1841

  4. Ostrega, D M

    • Adaptation to hyperglycemia enhances insulin secretion in glucokinase mutant mice. Diabetes December 1998 47:1881-1888; doi:10.2337/diabetes.47.12.1881

  5. Ovalle, F

    • Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes December 1998 47:1920-1927; doi:10.2337/diabetes.47.12.1920

P

  1. Paramore, D S

    • Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes December 1998 47:1920-1927; doi:10.2337/diabetes.47.12.1920

  2. Persson, M

    • Differential regulation of amino acid exchange and protein dynamics across splanchnic and skeletal muscle beds by insulin in healthy human subjects. Diabetes December 1998 47:1824-1835; doi:10.2337/diabetes.47.12.1824

  3. Pietzsch, J

    • In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance. Diabetes December 1998 47:1928-1934; doi:10.2337/diabetes.47.12.1928

  4. Pilcher, C

    • Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes December 1998 47:1857-1866; doi:10.2337/diabetes.47.12.1857

  5. Polonsky, K S

    • Adaptation to hyperglycemia enhances insulin secretion in glucokinase mutant mice. Diabetes December 1998 47:1881-1888; doi:10.2337/diabetes.47.12.1881

Q

  1. Quickel, R R

    • Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes December 1998 47:1894-1903; doi:10.2337/diabetes.47.12.1894

R

  1. Ramiya, V

    • Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells. Diabetes December 1998 47:1848-1856; doi:10.2337/diabetes.47.12.1848

  2. Roe, M W

    • Adaptation to hyperglycemia enhances insulin secretion in glucokinase mutant mice. Diabetes December 1998 47:1881-1888; doi:10.2337/diabetes.47.12.1881

S

  1. Schneider, B

    • Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment. Diabetes December 1998 47:1909-1914; doi:10.2337/diabetes.47.12.1909

  2. Shimabukuro, M

    • Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes. Diabetes December 1998 47:1904-1908; doi:10.2337/diabetes.47.12.1904

  3. Shi, Y

    • Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells. Diabetes December 1998 47:1848-1856; doi:10.2337/diabetes.47.12.1848

  4. Sobel, D O

    • Alpha-interferon inhibits the development of diabetes in NOD mice. Diabetes December 1998 47:1867-1872; doi:10.2337/diabetes.47.12.1867

  5. Sorisky, A

    • Expression and regulation of neuronal apoptosis inhibitory protein during adipocyte differentiation. Diabetes December 1998 47:1948-1952; doi:10.2337/diabetes.47.12.1948

  6. Sreenan, S K

    • Adaptation to hyperglycemia enhances insulin secretion in glucokinase mutant mice. Diabetes December 1998 47:1881-1888; doi:10.2337/diabetes.47.12.1881

  7. Stenger, D

    • Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes December 1998 47:1857-1866; doi:10.2337/diabetes.47.12.1857

  8. Stewart, T A

    • Adaptation to hyperglycemia enhances insulin secretion in glucokinase mutant mice. Diabetes December 1998 47:1881-1888; doi:10.2337/diabetes.47.12.1881

T

  1. Tarbell, J M

    • Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes December 1998 47:1953-1959; doi:10.2337/diabetes.47.12.1953

  2. Terkamp, C

    • Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes December 1998 47:1920-1927; doi:10.2337/diabetes.47.12.1920

  3. Thornalley, P J

    • Teratogenicity of 3-deoxyglucosone and diabetic embryopathy. Diabetes December 1998 47:1960-1966; doi:10.2337/diabetes.47.12.1960

  4. Tildesley, H

    • Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes. Diabetes December 1998 47:1915-1919; doi:10.2337/diabetes.47.12.1915

  5. Tobe, K

    • A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats. Diabetes December 1998 47:1841-1847; doi:10.2337/diabetes.47.12.1841

  6. Tornheim, K

    • Shared biochemical properties of glucotoxicity and lipotoxicity in islets decrease citrate synthase activity and increase phosphofructokinase activity. Diabetes December 1998 47:1889-1893; doi:10.2337/diabetes.47.12.1889

U

  1. Unger, R H

    • Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes. Diabetes December 1998 47:1904-1908; doi:10.2337/diabetes.47.12.1904

V

  1. Van Eylen, F

    • Contribution of Na/Ca exchange to Ca2+ outflow and entry in the rat pancreatic beta-cell: studies with antisense oligonucleotides. Diabetes December 1998 47:1873-1880; doi:10.2337/diabetes.47.12.1873

  2. Vasir, B

    • Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes December 1998 47:1894-1903; doi:10.2337/diabetes.47.12.1894

  3. Verge, C F

    • Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes December 1998 47:1857-1866; doi:10.2337/diabetes.47.12.1857

W

  1. Waldhäusl, W

    • Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment. Diabetes December 1998 47:1909-1914; doi:10.2337/diabetes.47.12.1909

  2. Wallace, P

    • Expression of mRNAs encoding uncoupling proteins in human skeletal muscle: effects of obesity and diabetes. Diabetes December 1998 47:1935-1940; doi:10.2337/diabetes.47.12.1935

  3. Weir, G C

    • Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes December 1998 47:1894-1903; doi:10.2337/diabetes.47.12.1894

  4. Wentzel, P

    • Teratogenicity of 3-deoxyglucosone and diabetic embryopathy. Diabetes December 1998 47:1960-1966; doi:10.2337/diabetes.47.12.1960

  5. Wojciechowski, B

    • Expression of mRNAs encoding uncoupling proteins in human skeletal muscle: effects of obesity and diabetes. Diabetes December 1998 47:1935-1940; doi:10.2337/diabetes.47.12.1935

Y

  1. Yaraghi, Z

    • Expression and regulation of neuronal apoptosis inhibitory protein during adipocyte differentiation. Diabetes December 1998 47:1948-1952; doi:10.2337/diabetes.47.12.1948

  2. Yazaki, Y

    • A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats. Diabetes December 1998 47:1841-1847; doi:10.2337/diabetes.47.12.1841

  3. Yoon, K H

    • Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes December 1998 47:1894-1903; doi:10.2337/diabetes.47.12.1894

Z

  1. Zhou, J

    • Regulation of glutamine:fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase. Diabetes December 1998 47:1836-1840; doi:10.2337/diabetes.47.12.1836

  2. Zhou, Y T

    • Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes. Diabetes December 1998 47:1904-1908; doi:10.2337/diabetes.47.12.1904

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement